JOHNSON & JOHNSON (JNJ)
Healthcare · Pharmaceutical Preparations
JOHNSON & JOHNSON (JNJ) stock research on InvestAtlant: institutional ownership from 13F filings, insider Form 4 activity, and SEC context.
Top institutional holders (2026-Q3)
| Institution | Shares | Value | % Outstanding |
|---|---|---|---|
| Ninety One UK Ltd | 6,491,294 | .72B | 0.21% |
| Sumitomo Mitsui Trust Group, Inc. | 5,475,151 | .45B | 0.18% |
| DekaBank Deutsche Girozentrale | 4,250,139 | .14M | 0.14% |
| MACKENZIE FINANCIAL CORP | 3,923,049 | .04B | 0.13% |
| Swedbank AB | 3,182,317 | $842.49M | 0.10% |
| PRINCIPAL FINANCIAL GROUP INC | 3,171,954 | $839.74M | 0.10% |
| Assenagon Asset Management S.A. | 2,990,726 | $791.76M | 0.10% |
| Bank Julius Baer & Co. Ltd, Zurich | 2,906,056 | $770.98M | 0.09% |
Recent insider transactions
| Date | Insider | Title | Type | Value |
|---|---|---|---|---|
| 2026-09-02 | Schmid Timothy | EVP, WW Chair, MedTech | Sale | $3.04M |
| 2026-09-02 | Schmid Timothy | EVP, WW Chair, MedTech | Sale | $6.19M |
| 2026-08-17 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Sale | $3.95M |
| 2026-08-13 | Duato Joaquin | CEO and Chairman of the Board, Director | Sale | $5.50M |
| 2026-08-13 | Duato Joaquin | CEO and Chairman of the Board, Director | Sale | $26.70M |
| 2026-08-06 | Forminard Elizabeth | EVP, Chief Legal Officer | Sale | $2.41M |
| 2026-08-06 | Forminard Elizabeth | EVP, Chief Legal Officer | Sale | .68M |
| 2026-08-05 | Duato Joaquin | CEO and Chairman of the Board, Director | Sale | .69M |